Compare ZURA & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZURA | CVGW |
|---|---|---|
| Founded | 2022 | 1924 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Foods |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.4M | 479.9M |
| IPO Year | N/A | 2002 |
| Metric | ZURA | CVGW |
|---|---|---|
| Price | $3.71 | $25.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $13.00 | ★ $33.50 |
| AVG Volume (30 Days) | ★ 856.3K | 285.1K |
| Earning Date | 05-14-2026 | 06-08-2026 |
| Dividend Yield | N/A | ★ 2.85% |
| EPS Growth | N/A | ★ 1950.00 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $648,434,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $652.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $18.40 |
| 52 Week High | $7.25 | $28.98 |
| Indicator | ZURA | CVGW |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 36.34 |
| Support Level | $3.25 | $25.41 |
| Resistance Level | $4.12 | $26.86 |
| Average True Range (ATR) | 0.25 | 0.44 |
| MACD | 0.00 | -0.16 |
| Stochastic Oscillator | 39.50 | 6.73 |
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.